Inositol News and Research

RSS
Transition, Elan to modify collaboration agreement for development, commercialization of ELND005

Transition, Elan to modify collaboration agreement for development, commercialization of ELND005

New analysis of Soliris in patients with PNH presented at ASH Annual Meeting

New analysis of Soliris in patients with PNH presented at ASH Annual Meeting

New analysis evaluates association between hemolysis, mortality in patients with PNH

New analysis evaluates association between hemolysis, mortality in patients with PNH

Breast cancer breakthrough

Breast cancer breakthrough

Loss of INPP5A gene can predict cutaneous squamous cell carcinoma progression

Loss of INPP5A gene can predict cutaneous squamous cell carcinoma progression

Elan and Transition Therapeutics report results of ELND005 Phase 2 study for Alzheimer's disease

Elan and Transition Therapeutics report results of ELND005 Phase 2 study for Alzheimer's disease

Penn researchers reverse cognitive decline in fruit flies with Alzheimer's gene mutation

Penn researchers reverse cognitive decline in fruit flies with Alzheimer's gene mutation

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

New research evaluating substantial disease burden of PNH presented at European Hematology Association

New research evaluating substantial disease burden of PNH presented at European Hematology Association

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Alexion Pharmaceuticals' Soliris NDA for PNH receives approval in Japan

Alexion Pharmaceuticals' Soliris NDA for PNH receives approval in Japan

Researchers find new genomic approach to identify smokers at risk of lung cancer

Researchers find new genomic approach to identify smokers at risk of lung cancer

Findings may help devise new strategies for Cryptococcus infections

Findings may help devise new strategies for Cryptococcus infections

New approach may circumvent lost response in insulin due to obesity

New approach may circumvent lost response in insulin due to obesity

Tips for reducing LDL cholesterol

Tips for reducing LDL cholesterol

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Study shows more women die of heart disease each year than men

Study shows more women die of heart disease each year than men

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Modifications to Phase II study AD201 and open label extension study AD251 for ELND005 notified

Modifications to Phase II study AD201 and open label extension study AD251 for ELND005 notified

Alexion Pharmaceuticals announces positive data from AEGIS study of Soliris

Alexion Pharmaceuticals announces positive data from AEGIS study of Soliris